Fetzima
Active substance: levomilnacipran
CAPSULE, EXTENDED RELEASE · LEVOMILNACIPRAN HYDROCHLORIDE 120 mg/1
United StatesActive
Marketing holder: Allergan, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LEVOMILNACIPRAN HYDROCHLORIDE · 120 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-b64b-77d6-8ac0-700d0213bde8,01a12090-d061-7708-b758-79c50c756fda,01a12092-9b10-75e9-9cb6-afa085df6b4e,01a12092-9b13-7cc8-abcf-5c9e1e9b33f9,01a1209e-58b3-7287-bfba-85ea2001b6d2;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0456-2212
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0456-2212 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0456-2212 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0456-2212 · Verified 2026-10-09 · open in source